<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id>
      <journal-title-group>
        <journal-title>BMC Research Notes</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1756-0500</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23256875</article-id>
      <article-id pub-id-type="pmc">3532086</article-id>
      <article-id pub-id-type="publisher-id">1756-0500-5-689</article-id>
      <article-id pub-id-type="doi">10.1186/1756-0500-5-689</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A rare association of localized scleroderma type morphea, vitiligo, autoimmune hypothyroidism, pneumonitis, autoimmune thrombocytopenic purpura and central nervous system vasculitis. Case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Bonilla-Abad&#xED;a</surname>
            <given-names>Fabio</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>fbac1982@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Mu&#xF1;oz-Buitr&#xF3;n</surname>
            <given-names>Evelyn</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>evelynmb_1@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Ochoa</surname>
            <given-names>Carlos D</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>carlosochoa79@yahoo.com</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Carrascal</surname>
            <given-names>Edwin</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>carrascal@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Ca&#xF1;as</surname>
            <given-names>Carlos A</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>cacd12@hotmail.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Rheumatology Unit. Fundaci&#xF3;n Valle del Lili, ICESI University, Avenida Sim&#xF3;n Bol&#xED;var Cra.98, No.18-49, Cali, Colombia</aff>
      <aff id="I2"><label>2</label>University of Medical Sciences, La Habana, Cuba</aff>
      <aff id="I3"><label>3</label>Fundaci&#xF3;n Valle del Lili, Cali, Colombia</aff>
      <aff id="I4"><label>4</label>Pathology Unit. Fundaci&#xF3;n Valle del Lili, and Faculty of Health Sciences, Universidad del Valle, Cali, Colombia</aff>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <volume>5</volume>
      <fpage>689</fpage>
      <lpage>689</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>9</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>12</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2012 Bonilla-Abad&#xED;a et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <copyright-holder>Bonilla-Abad&#xED;a et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/1756-0500/5/689"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>The localized scleroderma (LS) known as morphea, presents a variety of clinical manifestations that can include systemic involvement. Current classification schemes divide morphea into categories based solely on cutaneous morphology, without reference to systemic disease or autoimmune phenomena. This classification is likely incomplete. Autoimmune phenomena such as vitiligo and Hashimoto thyroiditis associated with LS have been reported in some cases suggesting an autoimmune basis. To our knowledge this is the first case of a morphea forming part of a multiple autoimmune syndrome (MAS) and presenting simultaneously with autoimmune thrombocytopenic purpura and central nervous system vasculitis.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We report an uncommon case of a white 53&#x2009;year old female patient with LS as part of a multiple autoimmune syndrome associated with pneumonitis, autoimmune thrombocytopenic purpura and central nervous system vasculitis presenting a favorable response with thrombopoietin receptor agonists, pulses of methylprednisolone and cyclophosphamide.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Is likely that LS have an autoimmune origin and in this case becomes part of MAS, which consist on the presence of three or more well-defined autoimmune diseases in a single patient.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Localized scleroderma</kwd>
        <kwd>Morphea</kwd>
        <kwd>Multiple autoimmune syndrome</kwd>
        <kwd>Central nervous system vasculitis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>The localized scleroderma (LS) is distinguished from systemic sclerosis not only by the absence of vasospasm, structural vascular damage, and involvement of internal organs, but also by the distribution of the skin lesions. LS, also known as morphea, presents a variety of clinical manifestations that can include systemic nvolvement 
[<xref ref-type="bibr" rid="B1">1</xref>]. Morphea is characterized by sclerosis of the skin and in some cases underlying tissue. Current classification schemes divide morphea into categories based solely on cutaneous morphology, without reference to systemic disease or autoimmune phenomena. This classification is likely incomplete 
[<xref ref-type="bibr" rid="B2">2</xref>]. Autoimmune phenomena such as vitiligo and Hashimoto thyroiditis associated with LS have been reported in some cases suggesting the possible autoimmune basis of morphea. We report an uncommon case of LS as part of a multiple autoimmune syndrome associated with pneumonitis and central nervous system vasculitis.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 53&#x2009;year old white female patient Jeovah witness was referred to our institution because of general and respiratory symptoms of several days consisting in malaise, weakness, decreased appetite, dyspnea, nonproductive cough, bleeding disorder compatible with idiopathic thrombocytopenic purpura (ITP) and sudden headache associated with diplopia and blurred vision. Her medical history included localized scleroderma type morphea in the lower limbs, vitiligo since 25&#x2009;years ago, autoimmune hypothyroidism, carpal tunnel and obesity.</p>
      <p>At physical examination on admission, her cardiopulmonary and abdominal examination was normal, no evidence of oral ulcers, alopecia, malar rash, synovitis, sclerodactyly, Raynaud phenomenon or dry symptoms. Hypopigmented lesions of vitiligo were observed in the lower limbs associated to atrophic violaceous plaques (Figure 
<xref ref-type="fig" rid="F1">1</xref>), these last lesions showing interstitial inflammation and homogenization of collagen in the histopathology study which was consistent with morphea (Figure 
<xref ref-type="fig" rid="F2">2</xref>). The neurological examination revealed diplopia and mild dysmetria. Initial studies showed pulmonary infiltrates and lung nodules of unclear etiology by X-ray and chest tomography. A fiberoptic bronchoscopy was performed evidenced only erythema of mucosa with negative bacteriological cultures. Echocardiogram was reported as normal. Laboratory test reported negative BK serial sputum. Clotting studies, renal function, C-reactive protein, bilirubin level and urine analysis were normal. Leukocytes count of 9830 cells/mm3 with normal hemoglobin and differential count and thrombocytopenia in the range of 41.000 which limited performing lung biopsy. Aspirate and flow cytometry in bone marrow were reported as normal, and there was no evidence of schistocytes in peripheral blood spread. Abdominal ultrasonography not demonstrated splenomegaly. Secondary infectious (HIV, hepatitis B and C, blood and urine cultures) and drug-related causes of thrombocytopenia were ruled. A brain computed tomography (CT) reported right and left gangliobasal and left lamellar intraventricular hemorrhage with ventricular drainage without evidence of arteriovenous malformation. Pulses of methylprednisolone were initiated in the context of intracerebral bleeding and autoimmune thrombocytopenia with unfavorable response and due to the inability of transfusion, hyperimmune human gamma globulin (0,5 gr/kg/day) was indicated. Refractoriness was presented to the application of gamma globulin and so it was necessary to use thrombopoietin receptor agonists (Eltrombopag) with a slow good response. Complementary autoimmune laboratory showed C3 136&#x2009;mg/dl (90&#x2013;180&#x2009;mg/dl), C4 18&#x2009;mg/dl (10&#x2013;40&#x2009;mg/dl), direct Coombs test, rheumatoid factor, Scl70, lupic anticoagulant, ANAs, AntiDNA, antineutrophil cytoplasmic antibodies (ANCAS) and anticardiolipins titles within normal limits, as well as extractable nuclear antigens (anti-Ro 7.7 U (&lt;20), anti-La 2.7 U (&lt;20), anti-Sm 1.9 U (&lt;20), and anti-RNP 4.8 U (&lt;20)). The antimicrosomal (45 UI/ml) and anti-thyroglobulin antibodies (21 UI/ml) were positive with TSH in normal range. Control lung imaging showed improvement of pulmonary involvement. Persistent headache, photophobia, nausea, emesis and diplopia made it necessary the realization of a cerebral magnetic resonance angiography that reported multiple cerebral parenchymals infarcts (right external capsule, left head caudate nucleus and bilateral occipital) with hemorrhagic transformation (Figure 
<xref ref-type="fig" rid="F3">3</xref>). Irregularity in cerebral arteries in "beads" pattern compatible with central nervous system (CNS) vasculitis was observed (Figure 
<xref ref-type="fig" rid="F4">4</xref>). Intracranial neoplasms of a primary and secondary nature, aneurysms and vascular malformations were ruled out by this study. A diagnosis of cerebral vasculitis was made in the light of findings requiring initiation of intravenous steroids (methylprednisolone 1&#x2009;gr/day per five days) and intravenous cyclophosphamide (1&#x2009;gr monthly) with clinical improvement and satisfactory recovery.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Vitiligo and morphea lesions on the lower limbs.</p>
        </caption>
        <graphic xlink:href="1756-0500-5-689-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Histopathologic examination of the morphea lesions, showing interstitial inflammation and the homogenization of collagen (hematoxylin and eosin stain, magnification x100).</p>
        </caption>
        <graphic xlink:href="1756-0500-5-689-2"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>MRI brain showed multiple cerebral infarctions with hemorrhagic transformation.</p>
        </caption>
        <graphic xlink:href="1756-0500-5-689-3"/>
      </fig>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Brain magnetic resonance angiography showed irregularity in the pattern of cerebral arteries in "beads".</p>
        </caption>
        <graphic xlink:href="1756-0500-5-689-4"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>LS associated with vitiligo and another autoinmune phenommena like Hashimoto&#x2019;s thyroiditis and autoimmune thrombocytopenic purpura have been rarely reported to occur simultaneously with evidence of improvement to treatment with systemic steroids 
[<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. Some studies have also indicated an association of autoimmune diseases and an increased frequency of serum autoantibodies with morphea 
[<xref ref-type="bibr" rid="B7">7</xref>]. In the literature, it has been raised that this association is more than coincidence, and it suggests an autoimmune basis for these conditions 
[<xref ref-type="bibr" rid="B8">8</xref>]. In other studies, elevated serum cytokines and cell adhesion molecules was related to the immune activation of localized scleroderma 
[<xref ref-type="bibr" rid="B9">9</xref>], as well as decreased regulatory T cells in patients with morphea contributing to loss of tolerance seen in this and other autoimmune diseases 
[<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. Also some non&#x2013;organ-specific autoimmune conditions like systemic lupus erythematosus 
[<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>], rheumatoid arthritis 
[<xref ref-type="bibr" rid="B14">14</xref>] and necrotizing vasculitis 
[<xref ref-type="bibr" rid="B15">15</xref>] have been reported associated with LS, in the latter case requiring the use of systemic steroids and cyclophosphamide with gradual improvement. Central nervous system (CNS) involvement and ophthalmologic manifestations in LS has been reported by several authors and, particularly, in linear scleroderma (en coup de sabre) and in progressive facial hemiatrophy 
[<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B16">16</xref>] and a report of LS associated with progressing ischemic stroke where it is thought that was caused by hemodynamic disturbances from localized sclerotic obstruction of the middle cerebral artery 
[<xref ref-type="bibr" rid="B17">17</xref>], however there are not clearly reports of association between morphea and central nervous system vasculitis. Table 
<xref ref-type="table" rid="T1">1</xref> summarizes some of the reports of LS associated with autoimmune diseases and the presence of autoantibodies. Is likely that LS have an autoimmune origin and in this case becomes part of a multiple autoimmune syndrome (MAS), which consist on the presence of three or more well-defined autoimmune diseases in a single patient 
[<xref ref-type="bibr" rid="B18">18</xref>]. To our knowledge this is the first case of a morphea forming part of a multiple autoimmune syndrome and presenting simultaneously with ITP and CNS vasculitis.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>LS associated with autoimmune diseases, presence of autoantibodies, treatment and response</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left" valign="top">
                <bold>Case</bold>
              </th>
              <th align="left" valign="top">
                <bold>Age, sex</bold>
              </th>
              <th align="left" valign="top">
                <bold>Morphea&#x2019;s location</bold>
              </th>
              <th align="left" valign="top">
                <bold>Associated autoimmune condition</bold>
              </th>
              <th align="left" valign="top">
                <bold>Positive autoantibodies</bold>
              </th>
              <th align="left" valign="top">
                <bold>Treatment</bold>
              </th>
              <th align="left" valign="top">
                <bold>Response to treatment</bold>
              </th>
              <th align="left" valign="top">
                <bold>Ref.</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="top">1<hr/></td>
              <td align="left" valign="top">48-year-old woman<hr/></td>
              <td align="left" valign="top">Plaques over the trunk<hr/></td>
              <td align="left" valign="top">Vitiligo, Hashimoto&#x2019;s thyroiditis<hr/></td>
              <td align="left" valign="top">Antithyroglobu- lin antibody, anti-thyroid peroxidaz<hr/></td>
              <td align="left" valign="top">Not described<hr/></td>
              <td align="left" valign="top">Not described<hr/></td>
              <td align="left" valign="top">3<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="top">2<hr/></td>
              <td align="left" valign="top">16-year-old girl<hr/></td>
              <td align="left" valign="top">On her trunk and right arm.<hr/></td>
              <td align="left" valign="top">Necrotizing vas- culitis of arterioles within the subcutaneous fat and muscles. Mononeuritis multiplex.<hr/></td>
              <td align="left" valign="top">Lupus anticoaglant test, Anti-DNA antibody, (LE) test, Anticardiolipin-&#x3B2;2GPI antibody<hr/></td>
              <td align="left" valign="top">Pulse therapy with 1&#x2009;g methyl prednisolone for 3&#x2009;days, cyclophosphamide (50&#x2009;mg/d).<hr/></td>
              <td align="left" valign="top">Gradually improved<hr/></td>
              <td align="left" valign="top">13<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="top">3<hr/></td>
              <td align="left" valign="top">16-year-old girl<hr/></td>
              <td align="left" valign="top">Umbilical region, right hemi thorax and back of the right hand<hr/></td>
              <td align="left" valign="top">Idiopathic thrombocytopenic purpura<hr/></td>
              <td align="left" valign="top">ANAS, Anti DNA<hr/></td>
              <td align="left" valign="top">Not described<hr/></td>
              <td align="left" valign="top">Not described<hr/></td>
              <td align="left" valign="top">6<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="top">4<hr/></td>
              <td align="left" valign="top">22-year-old woman<hr/></td>
              <td align="left" valign="top">Anterior chest<hr/></td>
              <td align="left" valign="top">Idiopathic thrombocytopenic purpura<hr/></td>
              <td align="left" valign="top">None<hr/></td>
              <td align="left" valign="top">Not described<hr/></td>
              <td align="left" valign="top">Not described<hr/></td>
              <td align="left" valign="top">6<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="top">Our case</td>
              <td align="left" valign="top">53&#x2009;year old woman</td>
              <td align="left" valign="top">Atrophic violaceous plaques in the lower limbs</td>
              <td align="left" valign="top">Vitiligo, autoimmune hypothyroidism, neumonitis, autoimmune thrombocytopenic purpura and central nervous system vasculitis</td>
              <td align="left" valign="top">Anti-microsomal and Anti-thyroglobulin antibodies</td>
              <td align="left" valign="top">Methylprednisolone 1&#x2009;gr/day per five days) and intravenous cyclophosphamide (1&#x2009;gr monthly</td>
              <td align="left" valign="top">Clinical improvement</td>
              <td align="left" valign="top">&#xA0;</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>Is likely that LS have an autoimmune origin supported by the reports described and its association with other autoimmune diseases, in this case forming part of MAS and with the aggravation to be associated with life-threatening conditions requiring aggressive treatment. This makes it important to look for systemic conditions in patients with localized scleroderma that may worsen the clinical localized disease.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this manuscript and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contribution</title>
      <p>CO and EM analyzed and interpreted the patient data regarding the rheumatology disease and the treatment. EC performed the histological examination of the skin. FB and CC were the major contributors in writing the manuscript. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Laxer</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Zulian</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Localized scleroderma</article-title>
          <source>Curr Opin Rheumatol</source>
          <year>2006</year>
          <volume>18</volume>
          <fpage>606</fpage>
          <lpage>613</lpage>
          <pub-id pub-id-type="doi">10.1097/01.bor.0000245727.40630.c3</pub-id>
          <pub-id pub-id-type="pmid">17053506</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Leitenberger</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Cayce</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Haley</surname>
            <given-names>RW</given-names>
          </name>
          <name>
            <surname>Adams-Huet</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Bergstresser</surname>
            <given-names>PR</given-names>
          </name>
          <name>
            <surname>Jacobe</surname>
            <given-names>HT</given-names>
          </name>
          <article-title>Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases</article-title>
          <source>Arch Dermatol</source>
          <year>2009</year>
          <volume>145</volume>
          <fpage>545</fpage>
          <lpage>550</lpage>
          <pub-id pub-id-type="doi">10.1001/archdermatol.2009.79</pub-id>
          <pub-id pub-id-type="pmid">19451498</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dervis</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Acbay</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Barut</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Karaoglu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ersoy</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Association of vitiligo, morphea, and Hashimoto's thyroiditis</article-title>
          <source>Int J Dermatol</source>
          <year>2004</year>
          <volume>43</volume>
          <fpage>236</fpage>
          <lpage>237</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-4632.2004.01973.x</pub-id>
          <pub-id pub-id-type="pmid">15009403</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bonifati</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Impara</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Morrone</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pietrangeli</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Carducci</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Simultaneous occurrence of linear scleroderma and homolateral segmental vit&#xED;ligo</article-title>
          <source>J Eur Acad Dermatol Venereol</source>
          <year>2006</year>
          <volume>20</volume>
          <fpage>63</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1468-3083.2005.01336.x</pub-id>
          <pub-id pub-id-type="pmid">16405610</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Neucks</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Moore</surname>
            <given-names>TL</given-names>
          </name>
          <name>
            <surname>Lichtenstein</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Baldassare</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Weiss</surname>
            <given-names>TD</given-names>
          </name>
          <name>
            <surname>Zuckner</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Localized scleroderma and idiopathic thrombocytopenia</article-title>
          <source>J Rheumatol</source>
          <year>1980</year>
          <volume>7</volume>
          <fpage>741</fpage>
          <lpage>744</lpage>
          <pub-id pub-id-type="pmid">7192318</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rond&#xF3;n</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Aguilar</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gallego</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Thrombopenia associated to localized scleroderma</article-title>
          <source>An Med Interna</source>
          <year>2001</year>
          <volume>18</volume>
          <fpage>88</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="pmid">11322006</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Harrington</surname>
            <given-names>CI</given-names>
          </name>
          <name>
            <surname>Dunsmore</surname>
            <given-names>IR</given-names>
          </name>
          <article-title>An investigation into the incidence of auto-immune disorders in patients with localized morphoea</article-title>
          <source>Br J Dermatol</source>
          <year>1989</year>
          <volume>120</volume>
          <fpage>645</fpage>
          <lpage>648</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2133.1989.tb01350.x</pub-id>
          <pub-id pub-id-type="pmid">2757929</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Soylu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>G&#xFC;l</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>G&#xF6;n&#xFC;l</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kili&#xE7;</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cakmak</surname>
            <given-names>SK</given-names>
          </name>
          <name>
            <surname>Demiriz</surname>
            <given-names>M</given-names>
          </name>
          <article-title>An uncommon presentation of the co-existence of morphea and vitiligo in a patient with chronic hepatitis B virus infection: is there a possible association with autoimmunity?</article-title>
          <source>Am J Clin Dermatol</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>336</fpage>
          <lpage>338</lpage>
          <pub-id pub-id-type="doi">10.2165/11310800-000000000-00000</pub-id>
          <pub-id pub-id-type="pmid">19658447</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Takehara</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sato</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Localized scleroderma is an autoimmune disorder</article-title>
          <source>Rheumatology (Oxford)</source>
          <year>2005</year>
          <volume>44</volume>
          <fpage>274</fpage>
          <lpage>279</lpage>
          <pub-id pub-id-type="doi">10.1093/rheumatology/keh487</pub-id>
          <pub-id pub-id-type="pmid">15561734</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Antiga</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Quaglino</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bellandi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Volpi</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Del Bianco</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Comessatti</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
          <article-title>Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea</article-title>
          <source>Br J Dermatol</source>
          <year>2010</year>
          <volume>162</volume>
          <issue>5</issue>
          <fpage>1056</fpage>
          <lpage>1063</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2133.2010.09633.x</pub-id>
          <pub-id pub-id-type="pmid">20105169</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lan</surname>
            <given-names>RY</given-names>
          </name>
          <name>
            <surname>Ansari</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Lian</surname>
            <given-names>ZX</given-names>
          </name>
          <name>
            <surname>Gershwin</surname>
            <given-names>ME</given-names>
          </name>
          <article-title>Regulatory T cells: development, function and role in autoimmunity</article-title>
          <source>Autoimmun Rev</source>
          <year>2005</year>
          <volume>4</volume>
          <issue>6</issue>
          <fpage>351</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="doi">10.1016/j.autrev.2005.01.007</pub-id>
          <pub-id pub-id-type="pmid">16081026</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shelkovitz-Shiloh</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Ehrenfeld</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Schewach-Millet</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Feinstein</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Coexistence of familial systemic lupus erythematosus and localized scleroderma</article-title>
          <source>Int J Dermatol</source>
          <year>1992</year>
          <volume>31</volume>
          <fpage>819</fpage>
          <lpage>820</lpage>
          <pub-id pub-id-type="pmid">1428438</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Majeed</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Al-Mayouf</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Al-Sabban</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Bahabri</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Coexistent linear scleroderma and juvenile systemic lupus erythematosus</article-title>
          <source>Pediatr Dermatol</source>
          <year>2000</year>
          <volume>17</volume>
          <fpage>456</fpage>
          <lpage>459</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1525-1470.2000.01820.x</pub-id>
          <pub-id pub-id-type="pmid">11123778</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hern&#xE1;ndez-Beriain</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Espinel</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>San Rom&#xE1;n</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Segura-Garc&#xED;a</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Morphea and rheumatoid arthritis</article-title>
          <source>Clin Exp Rheumatol</source>
          <year>1996</year>
          <volume>14</volume>
          <fpage>446</fpage>
          <lpage>447</lpage>
          <pub-id pub-id-type="pmid">8871848</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Morita</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tsuji</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Necrotizing vasculitis in a patient with generalized morphea</article-title>
          <source>Am Acad Dermatol</source>
          <year>2001</year>
          <volume>45</volume>
          <fpage>S215</fpage>
          <lpage>S217</lpage>
          <pub-id pub-id-type="doi">10.1067/mjd.2001.103640</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zulian</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Systemic manifestations in localized scleroderma</article-title>
          <source>Curr Rheumatol Rep</source>
          <year>2004</year>
          <volume>6</volume>
          <fpage>417</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="doi">10.1007/s11926-004-0020-5</pub-id>
          <pub-id pub-id-type="pmid">15527700</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kanzato</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Matsuzaki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Komine</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Saito</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Saito</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yoshio</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Suehara</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Localized scleroderma associated with progressing ischemic stroke</article-title>
          <source>J Neurol Sci</source>
          <year>1999</year>
          <volume>163</volume>
          <fpage>86</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-510X(98)00267-6</pub-id>
          <pub-id pub-id-type="pmid">10223417</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="other">
          <name>
            <surname>Anaya</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Castiblanco</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rojas-Villarraga</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pineda-Tamayo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Levy</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>G&#xF3;mez-Puerta</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dias</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mantilla</surname>
            <given-names>RD</given-names>
          </name>
          <name>
            <surname>Gallo</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Cervera</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Shoenfeld</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Arcos-Burgos</surname>
            <given-names>M</given-names>
          </name>
          <article-title>The Multiple Autoimmune Syndromes. A Clue for the Autoimmune Tautology</article-title>
          <source>Clin Rev Allergy Immunol</source>
          <year>2012</year>
          <comment>[Epub ahead of print]</comment>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
